New Pancreas Imaging Shows How Type 1 Diabetes Develops Before Symptoms Appear

Type 1 diabetes develops quietly in its early stages. People with autoantibodies—immune markers that signal the disease is beginning—often have no symptoms and normal blood sugar levels. What happens in the pancreas during this preclinical period has been largely a mystery, partly because pancreas samples from living people are rare.

A new study published in Nature Metabolism examined pancreatic tissue from 88 organ donors, including 28 with one autoantibody and 10 with multiple autoantibodies. Using advanced imaging technology, researchers analyzed 16 million individual cells and measured 79 different immune and beta cell markers to build a detailed picture of what occurs as type 1 diabetes progresses.

The imaging revealed a key partnership between two types of immune cells: pro-inflammatory macrophages and exhausted-like T cells (cells marked by proteins called PD1 and TIM3). These interactions were particularly common in the early, preclinical stages of disease and in areas where immune attack was happening in the islets—the clusters of cells that produce insulin.

This finding suggests that macrophages may play a more central role in launching type 1 diabetes than previously recognized. The exhausted-like appearance of the T cells is also notable; it hints that the immune response in type 1 diabetes may not simply be cells attacking at full strength, but rather a more complex interaction that changes how immune attack progresses.

The study also examined beta cells themselves to understand how they change before they are destroyed. Researchers found that beta cells in the earliest disease stages lost a protein called IAPP (islet amyloid polypeptide), which is normally present in healthy beta cells.

Surprisingly, the researchers did not find the endoplasmic reticulum stress markers they expected, even in pancreases with active immune attack. This challenges a leading theory about how beta cells break down in type 1 diabetes and suggests the actual process may be different from what lab studies have shown.

The analysis revealed that younger age was linked to greater immune activity in the pancreas, including more of several immune cell subtypes associated with insulitis (immune attack in the islets). This finding may help explain why children diagnosed with type 1 diabetes often experience more rapid progression and potentially more severe disease than adults who develop it later.

Understanding these age-related differences could be important for tailoring future treatments and monitoring strategies based on patient age.

This study creates a detailed map of the immune and beta cell changes that happen before type 1 diabetes becomes symptomatic—a window when intervention might be most effective. By identifying specific immune cell interactions and beta cell changes characteristic of early disease, the researchers have highlighted potential targets for future therapies.

The work is particularly valuable because it comes from real human pancreatic tissue rather than cell cultures or animal models, making the findings directly relevant to understanding the human disease. As research into prevention and early intervention continues, studies like this provide the foundation for knowing which immune cells and pathways to target.

Source: Nature metabolism. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.